Egyptian (OMX) Pharmaceuticals & Biotech Dividend Stocks

UPDATED May 18, 2024

Discover Egyptian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the OMX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NIPH

EI- Nile for Pharmaceuticals and Chemical Industries
ج.م68.750%86.1%ج.م696.1mn/aPE4.1xn/a7.3%

CPCI

Kahira Pharmaceuticals & Chemical Industries
ج.م69.190%82.0%ج.م1.0bn/aPE8.8xn/a7.2%

AXPH

Alexandria For Pharmaceuticals & Chemical Industries
ج.م215.080%58.0%ج.م1.1bn/aPE7.1xn/a6.0%

ADCI

Arab Drug
ج.م94.190%57.1%ج.م565.1mn/aPE7.6xn/a4.8%

PHAR

Egyptian International Pharmaceutical Industries
ج.م35.835.4%38.1%ج.م5.3bج.م75.30PE6.5xE14.2%2.8%

BIOC

GlaxoSmithKlineE
ج.م29.000.8%-10.9%ج.م2.4bn/aPE64.3xn/a2.6%

MPCI

Memphis Pharmaceuticals & Chemical Industries
ج.م80.07-0.3%198.4%ج.م450.4mn/aPE3.1xn/a2.5%

MIPH

MINAPHARM Pharmaceuticals
ج.م200.260%-4.6%ج.م2.2bn/aPB0.6xn/a0.8%

SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry
ج.م0.680%-28.6%ج.م170.0mn/aPE1503.3xn/a0%

OCPH

October PharmaE
ج.م100.000%0%ج.م1.2bn/aPE8xn/a0%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.